Lilly agrees to acquire Orna Therapeutics in an all-cash deal.
Novo Nordisk A/S aims to start selling its weight-loss blockbuster Wegovy in vials, its latest move to win over customers ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… ...
Eli Lilly is flying high thanks to its success in the GLP-1 space, but what comes next?
Mounjaro and Zepbound generated a combined $11.7 billion in sales for the company in its most recent quarter.
Eli Lilly and Company (NYSE:LLY) is included among 13 Best Long Term Low Risk Stocks to Buy Now. On February 5, Goldman Sachs ...
Eli Lilly (LLY) stock acquiring Orna Therapeutics for up to $2.4 billion to develop circular RNA CAR-T therapies for B ...
Eli Lilly and Company (NYSE:LLY) executives highlighted strong 2025 performance, continued demand for its incretin medicines, ...
7don MSN
Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar
Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit ...
The investment supports Eli Lilly and Company’s $3.5 billion expansion into Upper Macungie Township, marking the largest private-sector investment in Lehigh Valley history.
rocketcitynow.com on MSN
Huntsville council set to vote on Eli Lilly development
The Huntsville City Council will soon vote on a landmark $6 billion Eli Lilly campus, promising 450 jobs and significant economic growth in north Alabama.
The Lehigh Valley plant will be Indianapolis-based Lilly’s first manufacturing facility in Pennsylvania. Construction is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results